“Phase 2 Study of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s124, https://doi.org/10.25251/skin.4.supp.124.